𝔖 Bobbio Scriptorium

✦ LIBER ✦

A phase 2b trial of baricitinib, an oral JAK inhibitor, in patients with moderate to severe psoriasis

Book ID: 122313053
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 52 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.676

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apremilast, an oral phosphodiesterase 4

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: 16-week results of a phase 3, randomized, controlled trial (ESTEEM 2)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Apremilast, an oral phosphodiesterase 4

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: Results from the randomized treatment withdrawal phase of a phase 3, randomized, controlled trial (ESTEEM 1)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Tofacitinib (CP-690,550), an oral Janus

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

✍ Mamolo, C.; Harness, J.; Tan, H.; Menter, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

A phase 1/2A Trial of STA 5326, an oral

A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease

✍ Robert Burakoff; Charles F. Barish; Dennis Riff; Ronald Pruitt; William Y. Chey; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Long-term safety and tolerability of apr

Long-term safety and tolerability of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: Results from a phase III, randomized, controlled trial (ESTEEM 1)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PSS20 MEDIATION MODELING AND MEASUREMENT

PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS

✍ C. Mamolo; A.G. Bushmakin; J.C. Cappelleri; M. Stewart 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB